NCT05483621 is a Phase 1 clinical trial of Beta-hCG in Azoospermia, Nonobstructive, sponsored by Egymedicalpedia.

Who is sponsoring NCT05483621?

NCT05483621 is sponsored by Egymedicalpedia.

What drugs are being tested in NCT05483621?

Interventions in NCT05483621: Beta-hCG.

What condition does NCT05483621 study?

NCT05483621 studies Azoospermia, Nonobstructive.

Is NCT05483621 still recruiting?

NCT05483621 is currently completed. Last updated 19 October 2023.

Last reviewed 2023-10-19 · How we verify

NCT05483621

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hormonal Stimulation of Spermatogenesis

Completed Phase 1 Last updated 19 October 2023

What this trial tests

Phase 1 trial testing Beta-hCG in Azoospermia, Nonobstructive in 100 participants. Completed in 1 March 2022.

Timeline

1 March 2021

Primary endpoint
15 February 2022

1 March 2022

Quick facts

Lead sponsor	Egymedicalpedia
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	100
Start date	1 March 2021
Primary completion	15 February 2022
Estimated completion	1 March 2022
Sites	1 location across Egypt

Drugs / interventions tested

Beta-hCG — full drug profile →

Conditions studied

Azoospermia, Nonobstructive — all drugs for Azoospermia, Nonobstructive →

Sponsor

Egymedicalpedia — full company profile →

Who can join

Adults 19 to 72, male only, with Azoospermia, Nonobstructive. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Urologists and reproductive specialists are often challenged when facing patients with severe male infertility scenarios. In particular, the treatment of men with NOA demands a deeper insight. In such cases, .

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Azoospermia, Nonobstructive

Currently open trials in the same condition.

NCT03291522 — Retrieval of Sperm From Men With Azoospermia Using Ultrasound-guided Rete Testis Aspiration · active not recruiting
NCT06181851 — 2015-Metabolomics&Microbiome-infertility · recruiting

Other Egymedicalpedia trials

Trials by the same sponsor.

NCT06590818 — The Effect of Body Mass Index on Short-term Results of HTO · NA · recruiting
NCT06583811 — Remifentanil and Remimazolam to Limit Patient Movement · NA · recruiting
NCT06522984 — Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid · NA · recruiting
NCT06370078 — Effect of Early Administration of Albumin 20% Versus Crystalloid · NA · recruiting
NCT06370221 — The Effect of Psoriatic Arthritis on Female Sexual Dysfunction · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05483621 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Egymedicalpedia
Last refreshed: 19 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05483621.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing